{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:24:31Z","timestamp":1771644271456,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Asthma is a complex disease associated with many factors such as immunologic, environmental, genetic, and other factors. Common medicines used to treat asthma include \u03b2-agonist and glucocorticoid. However, in the long-term treatment, the effect of the above-mentioned drugs is not satisfactory, so many patients choose oral Chinese medicines instead of western medicines. The introduction of Chinese medicines therapies, a rapid proliferation of the literature on management of asthma in general, call for novel ways of evidence synthesis in this area. This systematic review is to systematically summarize and evaluate a large number of evidences for Chinese herbal interventions for asthma. Evaluate the efficacy and safety of Chinese medicines in the treatment of asthma and inform a decision aid for the clinical encounter between patients and clinicians. In addition, it helps to establish a future research agenda.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Five English databases (PubMed, Web of science, EBASE, Springer Cochrane Library, and WHO International Clinical Trials Registry Platform) and 4 Chinese databases (Wanfang Database, Chinese Scientific Journal Database, China National Knowledge Infrastructure Database, and Chinese Biomedical Literature Database) will be searched normatively according to the rule of each database from the inception to the present. The literature screening, data extraction, and quality assessment will be conducted by 2 researchers independently. Data will be synthesized by either the fixed-effects or random-effects model according to a heterogeneity test. Asthma control test symptom score will be assessed as the primary outcome. The curative effect of single symptom and sign; Withdrawal and reduction of western medicines in a course of treatment, including: time, type, and quantity; Maintenance of western medicines after the course of treatment, including: type, quantity; Asthma Quality of Life Questionnaire; laboratory efficacy indexes as the secondary outcome. General physical examination; routine examination of blood, urine, and stool; electrocardiogram; liver and kidney function examination; possible adverse reactions and related detection indicators as the security indexes. Meta-analysis will be performed using RevMan5.3.5 software provided by the Cochrane Collaboration.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study will provide high-quality synthesis based on current evidence of Chinese medicines treatment for asthma in several aspects, including asthma control score, side effects and laboratory examination such as lung-function test, serum total immunoglobulin, and so on.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The results of this study will provide updated evidence for whether Chinese medicines is an effective and safe intervention for asthma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PROSPERO registration number:<\/jats:title>\n            <jats:p>PROSPERO CRD42019136074.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016958","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:45:23Z","timestamp":1566528323000},"page":"e16958","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of Chinese medicines for asthma"],"prefix":"10.1097","volume":"98","author":[{"given":"Qi","family":"Shi","sequence":"first","affiliation":[{"name":"The 2nd Department of Pulmonary Disease in TCM, The Key Unit of SATCM Pneumonopathy Chronic Cough and Dyspnea, Beijing Key Laboratory of Prevention and Treatment of Allergic Diseases with TCM (No. BZ0321), Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxu","family":"Si","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Bao","sequence":"additional","affiliation":[{"name":"Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yan","sequence":"additional","affiliation":[{"name":"The 2nd Department of Pulmonary Disease in TCM, The Key Unit of SATCM Pneumonopathy Chronic Cough and Dyspnea, Beijing Key Laboratory of Prevention and Treatment of Allergic Diseases with TCM (No. BZ0321), Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Kong","sequence":"additional","affiliation":[{"name":"The 2nd Department of Pulmonary Disease in TCM, The Key Unit of SATCM Pneumonopathy Chronic Cough and Dyspnea, Beijing Key Laboratory of Prevention and Treatment of Allergic Diseases with TCM (No. BZ0321), Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Li","sequence":"additional","affiliation":[{"name":"The 2nd Department of Pulmonary Disease in TCM, The Key Unit of SATCM Pneumonopathy Chronic Cough and Dyspnea, Beijing Key Laboratory of Prevention and Treatment of Allergic Diseases with TCM (No. BZ0321), Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"He","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dashzeveg","family":"Damchaaperenlei","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxia","family":"Yu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlin","family":"Li","sequence":"additional","affiliation":[{"name":"The 2nd Department of Pulmonary Disease in TCM, The Key Unit of SATCM Pneumonopathy Chronic Cough and Dyspnea, Beijing Key Laboratory of Prevention and Treatment of Allergic Diseases with TCM (No. BZ0321), Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230914","first-page":"S0198-8859(19)30010-2","article-title":"Relationship between various cytokines implicated in asthma","volume":"pii","author":"Ayakannu","year":"2019","journal-title":"Hum Immunol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13020-018-0180-2","article-title":"Wentong decoction cures allergic bronchial asthma by regulating the apoptosis imbalance of EOS","volume":"13","author":"Yan","year":"2018","journal-title":"Chin Med"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rmed.2019.04.001","article-title":"Bronchodilators in subjects with asthma-related comorbidities","volume":"151","author":"Cazzola","year":"2019","journal-title":"Respir Med"},{"key":"R5-20230914","first-page":"897190019840597","article-title":"Comparison of monoclonal antibodies for treatment of uncontrolled eosinophilic asthma","volume":"2","author":"Koski","year":"2019","journal-title":"J Pharm Pract"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40413-018-0214-3","article-title":"Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study","volume":"11","author":"Canonica","year":"2018","journal-title":"World Allergy Organ J"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1900491","DOI":"10.1183\/13993003.00491-2019","article-title":"Asthma progression and mortality: the role of inhaled corticosteroids","volume":"54","author":"O\u2019Byrne","year":"2019","journal-title":"Eur Respir J"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12931-019-1056-4","article-title":"Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis","volume":"20","author":"Prazma","year":"2019","journal-title":"Respir Res"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"e10210","DOI":"10.2196\/10210","article-title":"Efficacy of an education session by pharmacists for patients with asthma: protocol and design of a randomized controlled trial","volume":"7","author":"Zairina","year":"2018","journal-title":"JMIR Res Protoc"},{"key":"R10-20230914","first-page":"5133","article-title":"Clinical efficacy of implementing Bio Immune(G)ene MEDicine in the treatment of chronic asthma with the objective of reducing or removing effectively corticosteroid therapy: a novel approach and promising results","volume":"15","author":"Glady","year":"2018","journal-title":"Exp Ther Med"},{"key":"R11-20230914","first-page":"1","article-title":"The impact of bronchial thermoplasty on asthma-related quality of life and controller medication use","volume":"2","author":"Seeley","year":"2019","journal-title":"Respiration"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/pai.13010","article-title":"The efficacy and safety of fluticasone\/salmeterol compared to fluticasone in children younger than four years of age","volume":"30","author":"Yoshihara","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1753466618824010","DOI":"10.1177\/1753466618824010","article-title":"Safety of tiotropium in patients with asthma","volume":"13","author":"Dusser","year":"2019","journal-title":"Ther Adv Respir Dis"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rmed.2019.02.003","article-title":"Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma","volume":"150","author":"Katsaounou","year":"2019","journal-title":"Respir Med"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12931-018-0742-y","article-title":"Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis","volume":"19","author":"Bloechliger","year":"2018","journal-title":"Respir Res"},{"key":"R16-20230914","first-page":"1","article-title":"The efficacy and safety of different long-acting beta2-agonists combined with inhaled glucocorticoid regimens in patients with asthma: a network meta-analysis","volume":"25","author":"Tang","year":"2018","journal-title":"J Asthma"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J Asthma Allergy"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/all.12273","article-title":"Characteristics of traditional Chinese medicine use in children with asthma: a nationwide population-based study","volume":"68","author":"Huang","year":"2013","journal-title":"Allergy"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0254-6272(12)60025-9","article-title":"Systematic review of randomized controlled trials of traditional Chinese medicine treatment of non-acute bronchial asthma complicated by gastroesophageal reflux","volume":"32","author":"Zhao","year":"2012","journal-title":"J Tradit Chin Med"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"846851","DOI":"10.1155\/2015\/846851","article-title":"A systematic and narrative review of acupuncture point application therapies in the treatment of allergic rhinitis and asthma during dog days","volume":"2015","author":"Wen","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"R21-20230914","first-page":"609","article-title":"Acupoint sticking therapy for treatment of bronchial asthma: a multicenter controlled randomized clinical trial","volume":"29","author":"Yao","year":"2009","journal-title":"Zhongguo Zhen Jiu"},{"key":"R22-20230914","first-page":"630","article-title":"Controlled study on different acupoint-prescription for the acupoint catgut embedding therapy in treatment of bronchial asthma","volume":"32","author":"Chen","year":"2012","journal-title":"Zhongguo Zhen Jiu"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0254-6272(09)60067-4","article-title":"TCM diet therapy for bronchial asthma","volume":"29","author":"Deng","year":"2009","journal-title":"J Tradit Chin Med"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fphar.2017.00944","article-title":"Yupingfeng San inhibits NLRP3 inflammasome to attenuate the inflammatory response in asthma mice","volume":"8","author":"Liu","year":"2017","journal-title":"Front Pharmacol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1142\/S0192415X15500615","article-title":"The immunoregulatory effects of traditional Chinese medicine on treatment of asthma or asthmatic inflammation","volume":"43","author":"Li","year":"2015","journal-title":"Am J Chin Med"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12906-015-0755-8","article-title":"Pingchuan formula improves asthma via restoration of the Th17\/Treg balance in a mouse model","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jep.2015.01.016","article-title":"Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17\/Treg imbalance in the murine ovalbumin asthma model","volume":"164","author":"Wei","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"e25867","DOI":"10.1136\/bmjopen-2018-025867","article-title":"Theory-based self-management intervention to improve adolescents\u2019 asthma control: a cluster randomised controlled trial protocol","volume":"9","author":"Harris","year":"2019","journal-title":"BMJ Open"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cct.2019.02.011","article-title":"Solving insomnia electronically: sleep treatment for asthma (SIESTA): a study protocol for a randomized controlled trial","volume":"79","author":"Shi","year":"2019","journal-title":"Contemp Clin Trials"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/oemed-2018-105434","article-title":"Performance of specific immunoglobulin E tests for diagnosing occupational asthma: a systematic review and meta-analysis","volume":"76","author":"Lux","year":"2019","journal-title":"Occup Environ Med"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.316.7129.469","article-title":"Bias in meta-analysis detected by a simple, graphical test. Experts\u2019 views are still needed","volume":"316","author":"Vandenbroucke","year":"1998","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201908230-00063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:15:53Z","timestamp":1694722553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201908230-00063"}},"subtitle":["A systematic review protocol"],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016958","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}